The Patent Finder

Compositions and Soft Tissue Replacement Methods

Allergan, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 12 of these applications claim priority to application 61/375,144, filed Aug 19, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,518,396Compositions and Methods for Soft Tissue Replacement
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,697,056Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,697,057Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,697,059Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,741,281Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,926,963Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 9,005,605Compositions and Soft Tissue Replacement Methods
In force
 · Medium confidence
Allergan, Inc.In force
Medium confidence
US 9,334,262Methods of Treating Soft Tissue Defects
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,889,123Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 8,900,571Compositions and Soft Tissue Replacement Methods
In force
 · High confidence
Allergan, Inc.In force
High confidence
3 more patents in this group · Pro
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13.
Upgrade to Pro
12 of these are in force and held by Allergan, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited